University of California San Francisco
Give to UCSF
Individuals who are hospitalized during pregnancy due to sepsis have higher odds of complications surrounding childbirth, according to a study led by researchers at UCSF. The study found that pregnancies complicated by sepsis were associated with an increased risk of cesarean delivery, postpartum hemorrhage and preterm delivery, highlighting the risk of any severe infection during pregnancy.
A clinical trial of new treatment regimens, led in part by researchers at UCSF, recently demonstrated that a more potent combination of antibiotics could shorten the duration of treatment for TB.
Most patients on immunosuppressive drugs for chronic inflammatory conditions, like rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease, can still produce antibodies after receiving the mRNA COVID-19 vaccines, researchers at UCSF and Washington University have concluded.
Individuals who contract COVID-19 while pregnant face a higher risk of having a very preterm birth, as well as any preterm birth.
We spoke to UCSF virologist Nadia Roan, PhD, about the latest developments in our knowledge of the Delta variant, including how the new variant spreads so efficiently, whether it causes more serious illness, and why she thinks vaccines will hold the line.
UCSF is responding to an increase in the number of community-acquired COVID-19 cases among its employees and learners.
UCSF and The Atlantic have announced that the crowdsourced digital archive documenting the face of the pandemic in the United States will become part of the University’s permanent library collection and is accessible to researchers and the public.
UCSF researchers in collaboration with the Centers for Disease Control’s Tuberculosis Trials Consortium and the AIDS Clinical Trials Group published a landmark study that demonstrated a new four-month treatment regimen for tuberculosis was safe and as efficacious as the standard six-month therapy.
Scientists at UCSF and Makerere University in Kampala, Uganda have developed an intervention that makes use of a portable laboratory testing technology to help HIV providers order, process, and receive HIV viral load results quickly, and shorten the time it takes for patients to get their results.
A UCSF study has found that the antibiotic azithromycin was no more effective than a placebo in preventing symptoms of COVID-19 among non-hospitalized patients, and may increase their chance of hospitalization, despite widespread prescription of the antibiotic for the disease.
Messenger RNA vaccines against COVID-19 were not detected in human milk, according to a small study by UCSF, providing early evidence that the vaccine mRNA is not transferred to the infant.
A study by UCSF researchers found that about one in four unvaccinated people aged 18 to 25 said that they “probably will not” or “definitely will not” get the COVID-19 vaccination.
